Friday, September 22, 2017 2:57:38 PM
reg2015,
Thanks for the vote of confidence but I have very seldom tried to contact anyone at NWBO. Only once did I speak to an actual employee and she was an office administrator. Another time I left a message of support for the company when they did the unexpected raise in December 2015 because I believed they needed to do this. I just wished they could have taken a bigger bite all at once. Their resources are really stretched so while I can try to interpret what I see as a critical need for the business my vision is limited compared to theirs so I give them the benefit of the doubt about how to handle their business affairs. Linda will do fine as she has set herself up for this after about 2 years without an appearance. Besides, I don't want to send an e-mail that might unknowingly have an attached virus. We don't want her to get the flu and miss another conference lol. Hang in there friend because we will have news of some sort soon enough now. Best wishes.
Thanks for the vote of confidence but I have very seldom tried to contact anyone at NWBO. Only once did I speak to an actual employee and she was an office administrator. Another time I left a message of support for the company when they did the unexpected raise in December 2015 because I believed they needed to do this. I just wished they could have taken a bigger bite all at once. Their resources are really stretched so while I can try to interpret what I see as a critical need for the business my vision is limited compared to theirs so I give them the benefit of the doubt about how to handle their business affairs. Linda will do fine as she has set herself up for this after about 2 years without an appearance. Besides, I don't want to send an e-mail that might unknowingly have an attached virus. We don't want her to get the flu and miss another conference lol. Hang in there friend because we will have news of some sort soon enough now. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
